genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Thermo Fisher to Acquire Brammer Bio for $1.7B, Expanding Gene Therapy…
News
Inflammation Has Transcription Factors on Its SIX to Regulate Out of…
News
Fathers’ Secondhand Smoke Puts Unborn Babies at Risk of Heart Defects
News
Chemicals in Household Dust Linked to Fat Cell Development
News
Address Manufacturing and Look Beyond Cancer, Panel Advises Cell and Gene…
Insights
Insights
Top 10 Immuno-Oncology Collaborations
Insights
Could Crocus Sativus (Saffron) Be as Effective as Stimulant Medicines in…
Commentary
Limitations in Single-Cell Analysis Must Be Addressed with Innovation
Cannabinoids
Liquid Gold: Engineers Strike Oil Making Customized Extractors for Cannabis
Bioprocessing
Addressing Challenges Posed by the Adoption of Single-Use Systems
A-Lists
Insights
Top 10 Immuno-Oncology Collaborations
Insights
Top 15 Best-Selling Drugs of 2018
March 2019 Vol. 39 No. 3
Top 10 Immuno-Oncology Startups
March 2019 Vol. 39 No. 3
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
10 Takeover Targets to Watch in 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Thermo Fisher to Acquire Brammer Bio for $1.7B, Expanding Gene Therapy…
Insights
Top 10 Immuno-Oncology Collaborations
News
Address Manufacturing and Look Beyond Cancer, Panel Advises Cell and Gene…
News
Cells Undergo Past Life Regression
Magazine
All
Supplement
Insights
Phage Therapy: Turning the Tables on Bacteria
March 2019 Vol. 39 No. 3
Keeping Up with Bioprocess Changes
March 2019 Vol. 39 No. 3
Circulating Tumor Cells and the Liquid Biopsy
Insights
Novel Oncology Drug Discovery Strategies
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
Multiplexed Target Enrichment and High-Resolution NGS Analysis of On- and…
Webinars
Fibro-Inflammatory Disease Sees Relief in IL-11 mAb Development
eBooks
End Uncertainty: Break Through the Roadblocks to Monoclonal Antibody (mAb) Characterization
GENcast
GENcast: Explore, Learn, and Collaborate on Cell & Gene Therapy Manufacturing…
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Companies
Abbvie
Abbvie
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Abbvie
AbbVie, Voyager Launch $1.5B+ Gene Therapy Collaboration Aimed at Parkinson’s, Other Synucleinopathies
Abbvie
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option
Abbvie
FDA Approves First Non-Chemo Combination Therapy for a Form of Leukemia
Abbvie
AbbVie, Lupin to Develop MALT1 Inhibitors for Blood Cancers in $977M+ Partnership
Abbvie
AbbVie Takes Control of Cystic Fibrosis Collaboration with Galapagos
Abbvie
AbbVie, Alphabet-Backed Calico Extend Aging Collaboration by $1B, Three Years
Abbvie
Ablynx, Protagonist Report Phase II Failures
Abbvie
Biogen, AbbVie Withdraw MS Drug Zinbryta after Brain Disorders Spark EMA...
Abbvie
AbbVie, Voyager Launch Up-to-$1.1B+ Gene-Therapy Collaboration to Treat Alzheimer’s, Neurodegenerative Diseases
Abbvie
Regeneron to Lead $50M Exome Sequencing Consortium with UK Biobank
Abbvie
AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations
Abbvie
AbbVie Gains Options for Up to Three Turnstone Cancer Viral Immunotherapies
Abbvie
Amgen Delaying U.S. Launch of Humira Biosimilar in Settlement with AbbVie
Abbvie
CytomX Wins $15M Milestone Payment from AbbVie for Cancer Probody–Drug Conjugate
Abbvie
AbbVie’s Veliparib Fails in Two Phase III Cancer Combination Therapy Studies
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
